Induction of neutralizing antibody and T-cell responses to Varicella- zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE)

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 709-719

  Garcia Valcarcel, Mercedes ^a   Fowler, Wendy J ^a   Harper, David R ^b   Jeffries, Donald J ^b   Layton, Guy T ^a  

^a British Biotech Pharmaceuticals Ltd   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

antibody; glycoprotein E; T cell responses; vaccine; Varicella zoster virus

Indexed keywords

EPITOPE; GLYCOPROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VACCINE; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MAPPING; GENE SEQUENCE; GUINEA PIG; HERPES ZOSTER; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; GUINEA PIGS; HERPESVIRUS 3, HUMAN; IMMUNODOMINANT EPITOPES; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDES; RETROELEMENTS; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS;

EID: 0030992213     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00228-9     Document Type: Article

References (38)

1. Grose, C. Variation on a theme by Fenner: The pathogenesis of chickenpox. Pediatrics 1981, 68, 735-737
2. Preblud, S.R., Orenstein, W.A., Koplan, J.P., Bart, K.J. and Hinman, A.R. A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad. Med. J. 1985, 61, 17-22
3. Lieu, T.A., Cochi, S.L., Black, S.B. et al. Cost effectiveness of a routine varicella vaccination program for US children. J. Am. Med. Assoc. 1994, 271, 375-381
4. Takahashi, T., Otsuka, Okuno, Y., Asano, Y., Yazaki, T. and Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974, 2, 1288-1290
5. Baba, K., Yabuuchi, H., Okuni, H. and Takahashi, M. Studies with live varicella vaccine and inactivated skin test antigen; protective effect of the vaccine and clinical application of the skin test. Pediatrics 1977, 61, 550-555
6. Gershon, A.A., Steinberg, S.P. and Gelb, L. The NIAID Varicella Vaccine Collaborative Study Group. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 1986, 78, 757-762
7. Watson, B., Keller, P.M., Ellis, R.W. and Starr, S.E. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity. J. Infect. Dis. 1990, 162, 794-799
8. Hickling, J.K., Borysiewicz, L.K. and Sissons, J.G.P. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J. Virol. 1987, 61, 3463-3469
9. Hyman, R.W. Structure and function of the varicella-zoster virus genome. In: The Human Herpesviruses: An Interdisciplinary Perspective (Eds Nahmias, A.J., Dowdle, W.R. and Schinazi, R.F.). Elsevier Press, New York, 1981, pp. 63-71
10. Davison, A.J. and Scott, J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 1986, 67, 1759-1816
11. Keller, P.M., Neff, B.J. and Ellis, R.W. Three major glycoprotein genes of varicella-zoster virus whose products have neutralisation epitopes. J. Virol. 1984, 52, 293-297
12. Arvin, A.M., Kinney-Thomas, E., Shriver, K. et al. Immunity to varicella-zoster viral glycoproteins gpI (gp90/58) and gpI-I(gp118) and to a non-glycosylated protein p170. J. Immunol. 1986, 137, 1346-1351
13. Vafai, A., Wroblewska, Z. and Mahalingam, R. et al. Recognition of similar epitopes on varicella-zoster virus gpI and gpIV by monoclonal antibodies. J. Virol. 1988, 62, 2544-2551
14. Forghani, B., Dupuis, K.W. and Schmidt, N.J. Epitopes functional in neutralization of varicella-zoster virus. J. Clin. Microbiol. 1990, 28, 2500-2506
15. Gershon A. A. Varicella in mother and infant: a problem old and new. In: Infections of the Fetus and the Newborn Infant (Eds Krugman, S. and Gershon, A.A.). Alan R. Liss, New York. 1975, pp. 79-95
16. Arvin, A.M. Cell-mediated immunity to varicella-zoster virus. J. Infect. Dis. 1992, 166, S35-41
17. Giller, R.H., Winistorfer, S. and Grose, C. Cellular and humoral immunity to varicella-zoster virus glycoproteins in immune and susceptible human subjects. J. Infect. Dis. 1989, 160, 919-925
18. Arvin, A.M. The T-lymphocyte response to varicella zoster virus and its relevance to vaccine development. Rev. Med. Virol. 1994, 4, 161-175
19. Sabella, C., Lowry, P.W., Abruzzi, G.M. et al. Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge. J. Virol. 1993, 67, 7673-7676
20. Brunell, P.A., Ross, A., Miller, L.H. and Kuo, B. Prevention of varicella by zoster immunoglobulin. N. Engl. J. Med. 1969, 280, 1191-1194
21. Arvin, A.M., Sharp, M., Smith, S. et al. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol. 1991, 146, 257-264
22. Hayward, A.R., Burger, R., Scheper, R. and Arvin, A.M. Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs. J. Virol. 1991, 65, 1491-1495
23. Mellor, J., Malim, M.H., Gull, K. et al. Reverse transcriptase activity and Ty RNA are associated with virus-like particles in yeast. Nature 1985, 318, 583-586
24. Adams, S.E., Dawson, K.M., Gull, K., Kingsman, S.M. and Kingsman, A.J. The expression of hybrid HIV:Ty virus-like particles in yeast. Nature 1987, 329, 68-70
25. Mills, K.H.G., Kitchin, P.A., Mahon, B.P. et al. HIV p24-specific helper T cell clones from immunised primates recognize highly conserved regions of HIV-1. J. Immunol. 1990, 144, 1677-1683
26. Griffiths, J.C., Berrie, E.L., Holdsworth, L.N. et al. Induction of high-titre neutralizing antibodies using hybrid human immunodeficiency virus V3-Ty virus-like particles in a clinically-relevant adjuvant. J. Virol. 1991, 65, 450-456
27. Harris, S.J., Gearing, A.J.H., Layton, G.T., Adams, S.E. and Kingsman, A.J. Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunisation with V3:Ty virus-like particles. Immunology 1992, 77, 315-321
28. Layton, G.T., Harris, S.J., Gearing, A.J.H. et al. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J. Immunol. 1993, 151, 1097-1107
29. Martin, S.J., Vyakarnam, A., Cheingsong-Popov, R. et al. Immunisation of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses. AIDS 1993, 7, 1315-1323
30. Fowler, W.J., Garcia-Valcarcel, M., Hill-Perkins, M.S. et al. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus. Virology 1995, 214, 531-540
31. Arvin, A.M., Solem, S.M., Koropchak, C.M., Kinney-Thomas, E. and Paryani, S.G. Humoral and cellular immunity to Varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p170, in the strain 2 guinea-pig. J. Gen. Virol. 1987, 68, 2449-2454
32. Vafai, A. Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine. Vaccine 1993, 11, 937-940
33. Vafai, A. Antibody-binding sites on truncated forms of varicella-zoster virus gpI (gE) glycoprotein. Vaccine 1994, 12, 1265-1269
34. Provost, P.J., Krah, D.L., Kuter, B.J. et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 1991, 9, 111-116
35. Krah, D., Klos, M., Hurni, W. et al. Correlation between VZV neutralizing antibody and gpELISA-reactive antibody in vaccinees. Abstract, The Second International Conference on the Varicella-zoster Virus, Paris, France 1994
36. Lowry, P.W., Solem, S., Watson, B.N. et al. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster glycoproteins I, IV, V or the protein product of the immediate early gene 62. J. Gen. Virol. 1992, 73, 811-819
37. Hayward, A., Giller, R. and Levin, M. Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes. Viral Immunol. 1989, 3, 175-184
38. Bergen, R.E., Sharp, M., Sanchez, A., Judd, A.K. and Arvin, A.M. Human T cells recognise multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella-zoster virus. Viral Immunol. 1991, 4, 151-166